Amgen Inc (AMGN)

AMGN (NASDAQ:Drugs) EQUITY
$152.29
pos +4.83
+3.28%
Today's Range: 147.25 - 152.35 | AMGN Avg Daily Volume: 3,571,100
Last Update: 09/02/15 - 4:00 PM EDT
Volume: 4,316,655
YTD Performance: -7.43%
Open: $149.07
Previous Close: $147.46
52 Week Range: $127.67 - $181.81
Oustanding Shares: 758,250,346
Market Cap: 115,087,237,516
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 1 1 1 1
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.13 2.13 2.13 2.13
Latest Dividend: 0.79
Latest Dividend Yield: 2.08%
Dividend Ex-Date: 08/13/15
Price Earnings Ratio: 20.10
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
20.10 20.10 24.87
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-6.09% 5.80% 75.72%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.40 0.29 0.09
Net Income 1.50 0.40 0.12
EPS 0.90 0.67 0.18
Earnings for AMGN:
EBITDA 8.74B
Revenue 20.06B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $2.36 $2.34 $9.72 $10.71
Number of Analysts 11 9 13 13
High Estimate $2.49 $2.43 $9.92 $11.75
Low Estimate $2.29 $2.22 $9.57 $10.19
Prior Year $2.30 $2.16 $8.68 $9.72
Growth Rate (Year over Year) 2.65% 8.13% 11.95% 10.21%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Chris Versace and Lenore Hawkins

 | Aug 26, 2015 | 2:00 PM EDT

We saw this coming, but there's more to the recent turmoil than China.

By

Bret Jensen

 | Aug 24, 2015 | 9:00 AM EDT

It could be time to deploy some of your dry powder.

By

Bret Jensen

 | Aug 18, 2015 | 1:00 PM EDT

Bet on small-caps with big-name collaborators.

By

Jim Cramer

 | Aug 10, 2015 | 5:40 AM EDT

There are some good buying ideas among these stocks.

By

Jim Cramer

 | Aug 1, 2015 | 9:00 AM EDT

Jim Cramer, portfolio manager of Action Alerts PLUS, and research director Jack Mohr sat down to talk about their 'favorite company in the portfolio:' Allergan.

By

Bob Byrne

 | Jul 31, 2015 | 7:00 AM EDT

Earnings report sinks stock, but that could create Friday trade.

By

Bryan Ashenberg

 | Jul 30, 2015 | 9:22 AM EDT

There is building consensus around a September rate hike.

By

Bret Jensen

 | Jul 29, 2015 | 7:39 AM EDT
I'm happy as always to be standing in for Doug Kass on the Daily Diary.
By

Bret Jensen

 | Jul 20, 2015 | 11:30 AM EDT

How Netflix, Tesla and Amazon are helping this market grind higher.

By

Jim Cramer

 | Jun 11, 2015 | 2:18 PM EDT

New companies are coming up with major drugs.

Been having very interesting exchanges on Twitter (started last night) about McDonald's --...
Nice to have a solid day in the market after yesterday big decline especially a rally that...
In mid July WHR held key support near the $160.00 area after blowing out support near...
Will a 250,000 print on the jobs data on Friday seal the deal for the Fed and allow them t...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.